The effect of plantago ointment on atopic dermatitis

Phase 3

Recruiting

• Conditions: Dermatit Atopic.; Atopic dermatitis

• Registration Number: IRCT20200304046695N1
• Lead Sponsor: Kerman University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 29 August 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 48

Inclusion Criteria

Approval of Hanifin and Rajka criteria for atopic dermatitis
Mild to moderate atopic dermatitis (SCORAD <50)
Poor response to conventional therapies (topical steroids and antihistamines)
Absence of exudate or infection Concomitant presence of systemic disease or dermatitis except atopic dermatitis
Written and informed consent of the patient

Exclusion Criteria

Taking oral or injectable steroids, antibiotics, phototherapy, and other immunosuppressive treatments (such as cyclosporine and azathioprine) but the corticosteroid position is not contraindicated.
Day Symptoms of drug intolerance such as severe heartburn and bloating
Existence of diseases that interfere with drug absorption, such as inflammatory bowel disease
Inability to participate regularly in follow-up

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Skin erythema. Timepoint: Before the intervention, 2 months after taking the drug, 15 days after the end of the course. Method of measurement: Based on scorad criteria.;Skin dryness. Timepoint: Before the intervention, 2 months after taking the drug, 15 days after the end of the course. Method of measurement: Based on scorad criteria.;Skin edema. Timepoint: Before the intervention, 2 months after taking the drug, 15 days after the end of the course. Method of measurement: Based on scorad criteria.;Skin itching. Timepoint: Before the intervention, 2 months after taking the drug, 15 days after the end of the course. Method of measurement: Based on scorad criteria.;Skin discharge. Timepoint: Before the intervention, 2 months after taking the drug, 15 days after the end of the course. Method of measurement: Based on scorad criteria.;Thickening of the skin. Timepoint: Before the intervention, 2 months after taking the drug, 15 days after the end of the course. Method of measurement: Based on scorad criteria.